Clinical trial / 2015
Cumin supplementation decreased weight, body mass index, and insulin levels in overweight adults
In a randomized trial of 78 overweight adults, taking Cuminum cyminum L. capsules three times daily for eight weeks reduced body weight (-1.1 ± 1.2 kg) and BMI (-0.4 ± 0.5 kg/m2) to a degree similar to orlistat, both differing from placebo (p = 0.002 and p = 0.003). Cumin also significantly decreased serum insulin (-1.4 ± 4.5 µIU/ml vs 1.3 ± 3.3 for orlistat and 0.3 ± 2.2 for placebo, p = 0.02) and improved insulin sensitivity markers.
- Study type
- Randomized controlled trial
- Who was studied
- 78 overweight adults aged 18-60 years
- What was measured
- Weight, body mass index, and insulin metabolism
THE PAPER
Effect of the cumin cyminum L. Intake on Weight Loss, Metabolic Profiles and Biomarkers of Oxidative Stress in Overweight Subjects: A Randomized Double-Blind Placebo-Controlled Clinical Trial.
Taghizadeh M, Memarzadeh MR, Asemi Z, Esmaillzadeh A. Ann Nutr Metab, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.